Curt D. Furberg

57.7k citations
403 papers · 40.2k · 22 hit papers · h-index 99

Impact in

Papers in

Curt D. Furberg

394 papers receiving 37.5k citations

Curt D. Furberg's Hit Papers

Fundamentals of Clinical Trials 2015 · 517 citations
5170+9+18Years since publication2505007501000

Peers

Curt D. Furberg
Comparison fields: 5 of 204
  • Cardiology and Cardiovascular Medicine 14.0k
  • Endocrinology, Diabetes and Metabolism 6.6k
  • Internal Medicine 644
  • Geriatrics and Gerontology 576
  • Nephrology 1.2k
Replace Rory Collins with:
Rory Collins United Kingdom
Diederick E. Grobbee Netherlands
Nancy R. Cook United States
Bruce M. Psaty United States
Michael Pencina United States
Stephen MacMahon Australia
Ian Ford United Kingdom
Hans Wedel Sweden
Julie E. Buring United States
Barry R. Davis United States
Curt D. Furberg relative to Rory Collins United Kingdom Rory Collins's profile →
Citations per field
00.5×1.5×
Rory Collins · 1×
Citations per year

Countries citing papers authored by Curt D. Furberg

Since Specialization
Citations

This map shows the geographic impact of Curt D. Furberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curt D. Furberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curt D. Furberg more than expected).

Fields of papers citing papers by Curt D. Furberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curt D. Furberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curt D. Furberg. The network helps show where Curt D. Furberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Curt D. Furberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Curt D. Furberg Line = papers co-authored together Curt D. Furberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 403 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The cardiovascular health study: Design and rationale
Hit paper breakdown →
19913040
2
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults
Hit paper breakdown →
19971159
3
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Hit paper breakdown →
20091029
4
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Hit paper breakdown →
2000971
5
Nifedipine
Hit paper breakdown →
1995900
6
Assessment of quality of life in clinical trials of cardiovascular therapies
Hit paper breakdown →
1984872
7
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Hit paper breakdown →
1994848
8
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents
Hit paper breakdown →
2003767
9
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Hit paper breakdown →
1994723
10
Primary Prevention of Ischemic Stroke
Hit paper breakdown →
2001696
11
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Hit paper breakdown →
2003681
12
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Hit paper breakdown →
2008664
13
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
Hit paper breakdown →
2007637
14
Use of Nonsteroidal Antiinflammatory Drugs
Hit paper breakdown →
2007635
15
Fundamentals of Clinical Trials
Hit paper breakdown →
1998589
16
Lipoprotein Management in Patients With Cardiometabolic Risk
Hit paper breakdown →
2008561
17
Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study
Hit paper breakdown →
2000545
18
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
Hit paper breakdown →
1995524
19
Fundamentals of Clinical Trials
Hit paper breakdown →
2015517
20 2000497

About Curt D. Furberg

Curt D. Furberg is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Surgery and Statistics and Probability, having authored 403 papers that have together received 40.2k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (62 papers), Health Systems, Economic Evaluations, Quality of Life (58 papers), Statistical Methods in Clinical Trials (46 papers), Lipoproteins and Cardiovascular Health (44 papers), Meta-analysis and systematic reviews (34 papers), Cardiac electrophysiology and arrhythmias (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Hormonal Regulation and Hypertension (21 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (14.0k citations), Endocrinology, Diabetes and Metabolism (6.6k citations), Internal Medicine (644 citations), Geriatrics and Gerontology (576 citations) and Nephrology (1.2k citations). Curt D. Furberg has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Bruce M. Psaty, Teri A. Manolio, Pentti M. Rautaharju, Sonal Singh, David L. DeMets, Lawrence M. Friedman, Yoon K. Loke, Lewis H. Kuller, Julius M. Gardin and Richard A. Kronmal. Their work appears in journals such as Circulation, The American Journal of Cardiology, Journal of the American College of Cardiology, Hypertension and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact